DBV FR0010417345

Report

Real-time Euronext Paris - 04/23 11:35:51 am
10.09	EUR		-1.37%

04/16

European ADRs Move Higher in Friday Trading

04/16

EGG ALLERGY PIPELINE : Emerging Therapies and Key pharma players involved by DelveInsight | Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others.

04/14

European ADRs Move Higher in Wednesday Trading

Summary

Quotes 5-day view Real-time Quote.

Real-time Euronext Paris

04/19/2021	04/20/2021	04/21/2021	04/22/2021	04/23/2021	Date
10.14(c)	9.866(c)	10.32(c)	10.23(c)	10.09	Last
451 052	413 063	301 555	197 400	246 829	Volume
-2.59%	-2.70%	+4.60%	-0.87%	-1.37%	Change

More quotes

Financials

Sales 2021	15,2 M 18,3 M 18,3 M
Net income 2021	-132 M -158 M -158 M
Net cash position 2021	85,1 M 102 M 102 M
P/E ratio 2021	-3,88x
Yield 2021	-

Sales 2022	50,6 M 60,9 M 60,9 M
Net income 2022	-112 M -134 M -134 M
Net cash position 2022	115 M 138 M 138 M
P/E ratio 2022	-6,10x
Yield 2022	-

Capitalization	561 M 674 M 675 M
EV / Sales 2021	31,4x
EV / Sales 2022	8,82x
Nbr of Employees	142
Free-Float	92,1%

More Financials

Company

DBV Technologies S.A. specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.

Sector

Pharmaceuticals

Calendar

05/03

Earnings Release

More about the company

Notations Surperformance© of DBV Technologies S.A.

Trading Rating :

Investor Rating :

More Ratings

All news about DBV TECHNOLOGIES S.A.

04/16	European ADRs Move Higher in Friday Trading	MT
04/16	EGG ALLERGY PIPELINE : Emerging Therapies and Key pharma players involved by Del..	AQ
04/14	European ADRs Move Higher in Wednesday Trading	MT
04/13	European ADRs Move Lower in Tuesday Trading	MT
04/08	European ADRs Move Higher in Thursday Trading	MT
04/07	European ADRs Move Higher in Wednesday Trading	MT
04/05	DBV TECHNOLOGIES : Announces Appointment of Timothy E. Morris to Board of Direc..	AQ
04/02	DBV TECHNOLOGIES S.A. : Change in Directors or Principal Officers, Regulation F..	AQ
04/02	DBV Technologies Announces Appointment of Timothy E. Morris to Board of Direc..	GL
04/02	DBV TECHNOLOGIES S.A. : Nomination	CO
03/29	DBV TECHNOLOGIES : Announces a New Chair of its Audit Committee and Date of its..	AQ
03/26	DBV TECHNOLOGIES S.A. : Change in Directors or Principal Officers, Regulation F..	AQ
03/26	DBV TECHNOLOGIES : Announces a New Chair of its Audit Committee and Date of its..	GL
03/26	DBV Technologies Announces a New Chair of its Audit Committee and Date of its..	GL
03/26	DBV TECHNOLOGIES S.A. : Nomination	CO

More news

News in other languages on DBV TECHNOLOGIES S.A.

04/19	DBV TECHNOLOGIES S A : AGM 2021 – Rapport du Conseil d'Administration à l..
04/16	DBV TECHNOLOGIES : plus forte baisse du SBF 120 à la clôture du vendredi 16 avr..
04/16	DBV TECHNOLOGIES : plus forte baisse du SRD à la clôture du vendredi 16 avril 2..
04/14	DBV TECHNOLOGIES S A : AGM 2021 – Avis Préalable à l'Assemblée Générale
04/06	STOCK MARKET PARIS : Le mois d'avril démarre fort

More news

Provided by Scoopnest.com

Chart DBV TECHNOLOGIES S.A.

Duration : Period :

DBV Technologies S.A. Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends DBV TECHNOLOGIES S.A.

	Short Term	Mid-Term	Long Term
Trends	Bullish	Bullish	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	UNDERPERFORM
Number of Analysts	4
Average target price	8,80 €
Last Close Price	10,23 €
Spread / Highest target	7,53%
Spread / Average Target	-14,0%
Spread / Lowest Target	-26,7%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Daniel Tassé	Chief Executive Officer & Executive Director
Sébastien Robitaille	Chief Financial Officer
Michel de Rosen	Non-Executive Chairman
Bertrand Dupont	Chief Technology Officer
Pharis Mohideen	Chief Medical Officer

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

DBV TECHNOLOGIES S.A.	135.93%	674



MERCK KGAA	2.96%	75 484
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD	24.73%	31 019
KYOWA KIRIN CO., LTD.	18.69%	16 591
SK BIOPHARMACEUTICALS CO., LTD.	-30.47%	8 223
BETTA PHARMACEUTICALS CO., LTD.	-6.86%	6 366

More Results